FDA approves Pfizer maternal RSV vaccine for infants CNBC

FDA approves Pfizer maternal RSV vaccine for infants  CNBC

The Food and Drug Administration on Monday approved a vaccine from Pfizer that protects infants from respiratory syncytial virus, the leading cause of hospitalization among babies in the U.S. Pfizer… [+4403 chars]Read More

Leave a Reply

Your email address will not be published. Required fields are marked *